Completed Dose-Escalation and Safety Trial of YN968D1 NCT01497704 Conditions Cancer Patients With Solid Tumors, Neoplasms Locations Huntsman Cancer Institute — Salt Lake City, Utah, United States ASAN Medical Center — Seoul, South Korea View Trial Details
Active, Not Recruiting Organotypic Platform for Therapeutic Investigation (OPTin) for Guiding Cancer Patients Treatment NCT07468422 Conditions Cancer (Advanced Stage), Cancer Patients With Solid Tumors, Neoplasms Locations China medical university hospital — Taichung, Taiwan View Trial Details
